ergoloid mesylates- dihydroergocornine mesylate, dihydroergocristine mesylate, dihydro-.alpha.-ergocryptine mesylate, and dihydr
sun pharmaceutical industries, inc. - dihydroergocornine mesylate (unii: 42rx8kpw29) (dihydroergocornine - unii:ik4c1oc8ne), dihydroergocristine mesylate (unii: ds7cl18uam) (dihydroergocristine - unii:05d48lum4z), dihydro-.alpha.-ergocryptine mesylate (unii: z4i7bu58dn) (dihydro-.alpha.-ergocryptine - unii:202229ir8y), dihydro-.beta.-ergocryptine mesylate (unii: 79y4u49i29) (epicriptine - unii:5m64643b5u) - dihydroergocornine mesylate 0.333 mg - a proportion of individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity (i.e., cognitive and interpersonal skills, mood, self-care, apparent motivation) can experience some symptomatic relief upon treatment with ergoloid mesylates preparations. the identity of the specific trait(s) or condition(s), if any, which would usefully predict a response to ergoloid mesylates therapy is not known. it appears, however, that those individuals who do respond come from groups of patients who would be considered clinically to suffer from some ill-defined process related to aging or to have some underlying dementing condition (i.e., primary progressive dementia, alzheimer's dementia, senile onset, multi-infarct dementia). before prescribing ergoloid mesylates, the physician should exclude the possibility that the patient's signs and symptoms arise from a potentially reversible and treatable condition. particular care should be taken to exclude delirium and dementiform illness secon
ergoloid mesylates- dihydroergocornine mesylate, dihydroergocristine mesylate, dihydro-.alpha.-ergocryptine mesylate, and dihydr
carilion materials management - dihydroergocornine mesylate (unii: 42rx8kpw29) (dihydroergocornine - unii:ik4c1oc8ne), dihydroergocristine mesylate (unii: ds7cl18uam) (dihydroergocristine - unii:05d48lum4z), dihydro-.alpha.-ergocryptine mesylate (unii: z4i7bu58dn) (dihydro-.alpha.-ergocryptine - unii:202229ir8y), dihydro-.beta.-ergocryptine mesylate (unii: 79y4u49i29) (epicriptine - unii:5m64643b5u) - dihydroergocornine mesylate 0.333 mg - a proportion of individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity (i.e., cognitive and interpersonal skills, mood, self-care, apparent motivation) can experience some symptomatic relief upon treatment with ergoloid mesylates preparations. the identity of the specific trait(s) or condition(s), if any, which would usefully predict a response to ergoloid mesylates therapy is not known. it appears, however, that those individuals who do respond come from groups of patients who would be considered clinically to suffer from some ill-defined process related to aging or to have some underlying dementing condition (i.e., primary progressive dementia, alzheimer's dementia, senile onset, multi-infarct dementia). before prescribing ergoloid mesylates, the physician should exclude the possibility that the patient's signs and symptoms arise from a potentially reversible and treatable condition. particular care should be taken to exclude delirium and dementiform illness secon
brinerdin tab tablet
novartis - clopamide, dihydroergocristine, reserpine - tablet - 0.5 , 5 , 0.1 mg
novofluen
karl engelhard - dihydroergocristine -
ergoloid mesylates tablets usp oral 1mg
frontida biopharm, inc. - dihydroergocornine mesylate (unii: 42rx8kpw29) (dihydroergocornine - unii:ik4c1oc8ne), dihydroergocristine mesylate (unii: ds7cl18uam) (dihydroergocristine - unii:05d48lum4z), dihydro-.alpha.-ergocryptine mesylate (unii: z4i7bu58dn) (dihydro-.alpha.-ergocryptine - unii:202229ir8y), dihydro-.beta.-ergocryptine mesylate (unii: 79y4u49i29) (epicriptine - unii:5m64643b5u) -
brinerdin
dihydroergocristine 0.5mg clopamide 5mg, reserpine 0.1mg
brinerdin tablets (pom)
dihydroergocristine 0.5g, clopamide 5mg, reserpine 0.1mg
sinepress tabs
reserpine 0.1mg hydrochlorothiazide 10mg dihydroergocristine mesylate0,6mg
brinerdin tabs
reserpine 0.1mg. clopamide 5mg dihydroergocristine 0.5mg
almirid 5mg capsules 5 milligram capsule
polichem s.a. - dihydroergocryptine mesilate - capsule - 5 milligram